» Articles » PMID: 34611216

Lung Microbiome of Stable and Exacerbated COPD Patients in Tshwane, South Africa

Overview
Journal Sci Rep
Specialty Science
Date 2021 Oct 6
PMID 34611216
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by the occurrence of exacerbations triggered by infections. The aim of this study was to determine the composition of the lung microbiome and lung virome in patients with COPD in an African setting and to compare their composition between the stable and exacerbated states. Twenty-four adult COPD patients were recruited from three hospitals. Sputum was collected and bacterial DNA was extracted. Targeted metagenomics was performed to determine the microbiome composition. Viral DNA and RNA were extracted from selected samples followed by cDNA conversion. Shotgun metagenomics sequencing was performed on pooled DNA and RNA. The most abundant phyla across all samples were Firmicutes and Proteobacteria. The following genera were most prevalent: Haemophilus and Streptococcus. There were no considerable differences for alpha and beta diversity measures between the disease states. However, a difference in the abundances between disease states was observed for: (i) Serratia (3% lower abundance in exacerbated state), (ii) Granulicatella (2.2% higher abundance in exacerbated state), (iii) Haemophilus (5.7% higher abundance in exacerbated state) and (iv) Veillonella (2.5% higher abundance in exacerbated state). Virome analysis showed a high abundance of the BeAn 58058 virus, a member of the Poxviridae family, in all six samples (90% to 94%). This study is among the first to report lung microbiome composition in COPD patients from Africa. In this small sample set, no differences in alpha or beta diversity between stable and exacerbated disease state was observed, but an unexpectedly high frequency of BeAn 58058 virus was observed. These observations highlight the need for further research of the lung microbiome of COPD patients in African settings.

Citing Articles

Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease.

Stankovic M Int J Mol Sci. 2025; 26(4).

PMID: 40003871 PMC: 11854937. DOI: 10.3390/ijms26041403.


The virome composition of respiratory tract changes in school-aged children with Mycoplasma pneumoniae infection.

Zhang D, Cao Y, Dai B, Zhang T, Jin X, Lan Q Virol J. 2025; 22(1):10.

PMID: 39806507 PMC: 11731546. DOI: 10.1186/s12985-025-02626-9.


The microbiome and the eye: a new era in ophthalmology.

Kaur S, Patel B, Collen A, Malhotra R Eye (Lond). 2024; 39(3):436-448.

PMID: 39702789 PMC: 11794629. DOI: 10.1038/s41433-024-03517-z.


A clinical metagenomic study of biopsies from Mexican endophthalmitis patients reveals the presence of complex bacterial communities and a diversity of resistance genes.

Vences-Guzman M, Jimenez-Rodriguez M, Lozano L, Rojas-Juarez S, Ramirez-Estudillo J, Hernandez-Vazquez A Access Microbiol. 2024; 6(6).

PMID: 39045243 PMC: 11261729. DOI: 10.1099/acmi.0.000639.v3.


Exploring the Complexity of the Human Respiratory Virome through an In Silico Analysis of Shotgun Metagenomic Data Retrieved from Public Repositories.

Conradie T, Caparros-Martin J, Egan S, Kicic A, Koks S, Stick S Viruses. 2024; 16(6).

PMID: 38932245 PMC: 11209621. DOI: 10.3390/v16060953.


References
1.
Park S, Kim J . Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing. Int Neurourol J. 2016; 20(Suppl 2):S76-83. PMC: 5169091. DOI: 10.5213/inj.1632742.371. View

2.
DAnna S, Balbi B, Cappello F, Carone M, Di Stefano A . Bacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects. Int J Chron Obstruct Pulmon Dis. 2016; 11:445-53. PMC: 4780195. DOI: 10.2147/COPD.S93398. View

3.
Bouquet J, Tabor D, Silver J, Nair V, Tovchigrechko A, Griffin M . Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res. 2020; 21(1):77. PMC: 7104712. DOI: 10.1186/s12931-020-01340-0. View

4.
Carney S, Clemente J, Cox M, Dickson R, Huang Y, Kitsios G . Methods in Lung Microbiome Research. Am J Respir Cell Mol Biol. 2019; 62(3):283-299. PMC: 7055701. DOI: 10.1165/rcmb.2019-0273TR. View

5.
Terzikhan N, Verhamme K, Hofman A, Stricker B, Brusselle G, Lahousse L . Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016; 31(8):785-92. PMC: 5005388. DOI: 10.1007/s10654-016-0132-z. View